title: Target regimen profiles for treatment of tuberculosis: a WHO document.
authors.affiliation: Global TB Programme (GTB), World Health Organization, Geneva, Switzerland lienhardtc@who.int.
authors.forename: Christian
authors.initials: C
authors.lastname: Lienhardt
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco General Hospital, San Francisco, CA, USA.
authors.forename: Payam
authors.initials: P
authors.lastname: Nahid
authors.affiliation: Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.|Harvard Medical School, Boston, MA, USA.|Partners In Health, Boston, MA, USA.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Rich
authors.affiliation: Global Health Program, Bill & Melinda Gates Foundation, Seattle, WA, USA.
authors.forename: Cathy
authors.initials: C
authors.lastname: Bansbach
authors.affiliation: Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Emily A
authors.initials: EA
authors.lastname: Kendall
authors.affiliation: Aurum Institute, Johannesburg, South Africa.|School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
authors.forename: Gavin
authors.initials: G
authors.lastname: Churchyard
authors.affiliation: Global TB Programme (GTB), World Health Organization, Geneva, Switzerland.
authors.forename: Lice
authors.initials: L
authors.lastname: González-Angulo
authors.affiliation: World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy.
authors.forename: Lia
authors.initials: L
authors.lastname: D'Ambrosio
authors.affiliation: World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy.
authors.forename: Giovanni Battista
authors.identifier: 0000-0002-2597-574X
authors.initials: GB
authors.lastname: Migliori
authors.affiliation: Global TB Programme (GTB), World Health Organization, Geneva, Switzerland.
authors.forename: Mario
authors.initials: M
authors.lastname: Raviglione
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003140:Communicable Disease Control; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D006801:Humans; D055552:Infectious Disease Medicine / Q000592:standards*; D008962:Models, Theoretical; D015272:Pulmonary Medicine / Q000592:standards; D012293:Rifampin / Q000008:administration & dosage*; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents; D012293:Rifampin